Swedish medical technology company RaySearch Laboratories AB and Radiology Oncology Systems Inc (ROS), a US provider of radiation therapy and diagnostic imaging equipment, on Friday announced a strategic partnership aiming at identifying and pursuing opportunities involving both emerging and existing technologies, with focus on the integration of refurbished linear accelerators with advanced software solutions.
According to RaySearch and ROS, the purpose of the partnership is to jointly offer comprehensive solutions that expand access to radiation therapy, ensure high-quality care, and strengthen each party's market position. The collaboration has already resulted in several agreements.
RaySearch says that currently, many fully functional linear accelerators are routinely scrapped after 10 years, instead of being refurbished and used in centres that lack cancer treatment technology. Together, the parties says that they will work on the refurbished market, contribute to circularity, and extend the lifecycle of linear accelerators -- advancing sustainability in radiation therapy. For RaySearch, the partnership will support a wider adoption of RayStation and RayCare.
Orders have already been placed by two centres in Argentina, both equipped with Varian Trilogy linear accelerators, one centre in the USA, using TrueBeam and RayStation, and a Mexican centre using Elekta Versa HD and RayStation.
Actuate Therapeutics advances Ewing Sarcoma trial following positive Phase 1 results
Citius Oncology prices USD9.0m public offering
Innovent Biologics' Phase 1 anti-CLDN18.2 ADC (IBI343) results published in Nature Medicine
Varian launches IntelliBlate in Europe, expanding image-guided microwave ablation for cancer care
Imugene announces Azer-cel Phase 1b clinical trial data
CARsgen successfully defends European GPC3 CAR-T patent
IGI and AbbVie enter global licensing agreement for ISB 2001